Calyxt, Inc. Share Price Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Sales 2024 * | 2.12M 177M | Sales 2025 * | 8.34M 696M | Capitalization | 369M 30.79B |
---|---|---|---|---|---|
Net income 2024 * | -84M -7.01B | Net income 2025 * | -87M -7.26B | EV / Sales 2024 * | 174 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 44.2 x |
P/E ratio 2024 * |
-5.63
x | P/E ratio 2025 * |
-7.57
x | Employees | 183 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.53% |
Latest transcript on Calyxt, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
1st Jan change | Capi. | |
---|---|---|
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
+27.02% | 108B | |
-1.14% | 62.54B | |
+7.23% | 52.22B | |
+12.58% | 51.73B | |
+1.61% | 41.4B | |
+5.32% | 37.17B |